Dr. Helena Devos
ActiveSummary
Dr. Helena Devos has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €519,279 and a net result of €359,953. Equity is growing by ~10% per year across the filed fiscal years. Its solvency ranks better than 95% of 19922 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
What they do
Specialist medical practice
NACE 86220
1 site
How big
€535,529total assets 2024
- Equity
- €519,279
- Profit
- €359,953
Turnover not published (abridged schema)
Who decides
Accounts 62 d overdue0 of 4 deeds read
Why 99+ Lower-failure-rate sector+ Annual accounts: healthy financial profile+ Long track recordFiled after the deadlineShow the evidence
Checked score
Score 2024
Axes · tick = 2023
Profitability100=
Solvency100▲+35
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €50,000 at 30 days acceptable
Liquidity ample (current ratio 28.88 against 1.42 in 2023; short-term debt: 3% and cash: 71% of total assets), and 3% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
97%
Return on assets
67.2%
Age of the figures
21 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 28-10-2025, 89 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
89 d late
2023
30 d early
2022
55 d early
2021
10 d early
2020
40 d early
2019
21 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 11 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (1)
- Annual accounts filedfiscal year 2024 · micro…
- Liquidity times 20current ratio 28.88
- Equity above €500,000Eq €519,279 ▲122%
Financials
Fiscal year 2024Total assets €535,529Profit €359,953Solvency 97.0%Liquidity 28.88
Total assets
€535,529▼ 9.2%
2019 - 2024
Net result
€359,953▼ 19.4%
2019 - 2024
Equity
€519,279▲ 122%
2019 - 2024
Solvency
97.0%▲ 57.2pp
2019 - 2024
Financials · fiscal year 2024, micro schema
Trend over the years
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€295,059▼ 6.5%€425,203▲ 44.1%€414,082▼ 2.6%€591,952▲ 43.0%€459,944▼ 22.3%
Net result€217,436above the sector's middle half▼ 6.0%€332,438above the sector's middle half▲ 52.9%€314,352above the sector's middle half▼ 5.4%€446,543above the sector's middle half▲ 42.1%€359,953above the sector's middle half▼ 19.4%
Equity€175,993within the sector's middle half▲ 6.9%€488,431above the sector's middle half▲ 178%€142,783within the sector's middle half▼ 70.8%€234,326within the sector's middle half▲ 64.1%€519,279above the sector's middle half▲ 122%
Total assets€430,884within the sector's middle half▲ 32.8%€509,292within the sector's middle half▲ 18.2%€508,567within the sector's middle half▼ 0.1%€589,592within the sector's middle half▲ 15.9%€535,529within the sector's middle half▼ 9.2%
Debt€254,891▲ 59.3%€20,861▼ 91.8%€365,784▲ 1,653%€355,266▼ 2.9%€16,251▼ 95.4%
Working capital€64below the sector's middle half€301,002above the sector's middle half▲ 468,531%€2,949below the sector's middle half▼ 99.0%€149,213within the sector's middle half▲ 4,960%€453,119above the sector's middle half▲ 204%
Solvency40.8%within the sector's middle half▼ 9.9pp95.9%above the sector's middle half▲ 55.1pp28.1%below the sector's middle half▼ 67.8pp39.7%within the sector's middle half▲ 11.7pp97.0%above the sector's middle half▲ 57.2pp
Current ratio1.00below the sector's middle half▲ 0.2515.67above the sector's middle half▲ 14.671.01below the sector's middle half▼ 14.671.42within the sector's middle half▲ 0.4128.88above the sector's middle half▲ 27.46
Return on assets (ROA)50.5%above the sector's middle half▼ 20.8pp65.3%above the sector's middle half▲ 14.8pp61.8%above the sector's middle half▼ 3.5pp75.7%above the sector's middle half▲ 13.9pp67.2%above the sector's middle half▼ 8.5pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result and balance sheet
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 22% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €535,529
Fixed assets
€66,160 ▼ 22.3%
Current assets
€469,369 ▼ 7.0%
Equity and liabilities €535,529
Equity
€519,279 ▲ 122%
Debt
€16,251 ▼ 95.4%
Debt's share of the balance-sheet total falls from 60.3% to 3.0%. Equity is higher and debt is lower.
Key figures and ratios
Key figures and ratios
EBITDA
€478,896▼
2023 · €647,021
Cash flow
€378,906▼
2023 · €501,612
Debt to equity
0.03▼
2023 · 1.52
ROE
69.3%▼
2023 · 190.6%
Interest coverage
6841.38▲
2023 · 578.85
Debt ≤ 1 year
€16,251▼
2023 · €355,266
Income taxes
€112,184▼
2023 · €145,835
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 17,811 companies that looked in July 2024 the way this one looks now, 0.3% went bankrupt within 24 months and 97% are still going.
- Small
- 10 to 20 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.3%
went bankrupt
3.2%
stopped otherwise
97%
still going
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 17,811 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Filed annual accounts
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €43,562 | €48,240 | €48,566 | €55,069 | €18,952 | ▼ 65.6% |
| Other operating charges640/8 | - | - | €1,110 | €3,891 | €855 | ▼ 78.0% |
| Gross operating margin9900 | €339,681 | €474,813 | €463,759 | €650,912 | €479,751 | ▼ 26.3% |
| Operating profit (loss)9901 | €295,059 | €425,203 | €414,082 | €591,952 | €459,944 | ▼ 22.3% |
| Financial income75/76B | - | - | €2,071 | €1,544 | €12,263 | ▲ 694% |
| Recurring financial income75 | €1,962 | €7,946 | €2,071 | €1,544 | €12,263 | ▲ 694% |
| Financial charges65/66B | - | - | €876 | €1,118 | €70 | ▼ 93.7% |
| Recurring financial charges65 | €419 | €314 | €876 | €1,118 | €70 | ▼ 93.7% |
| Profit (loss) for the period before taxes9903 | €296,602 | €432,836 | €415,277 | €592,378 | €472,138 | ▼ 20.3% |
| Income taxes67/77 | €79,166 | €100,398 | €100,926 | €145,835 | €112,184 | ▼ 23.1% |
| Profit (loss) for the period9904 | €217,436 | €332,438 | €314,352 | €446,543 | €359,953 | ▼ 19.4% |
| Profit (loss) for the period to be appropriated9905 | €217,436 | €332,438 | €314,352 | €446,543 | €359,953 | ▼ 19.4% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €430,884 | €509,292 | €508,567 | €589,592 | €535,529 | ▼ 9.2% |
| Fixed assets21/28 | €176,276 | €187,776 | €140,181 | €85,112 | €66,160 | ▼ 22.3% |
| Tangible fixed assets22/27 | €176,276 | €187,776 | €140,181 | €85,112 | €66,160 | ▼ 22.3% |
| Furniture and vehicles24 | - | - | €27,512 | €463 | €139 | ▼ 69.9% |
| Other tangible fixed assets26 | - | - | €112,669 | €84,649 | €66,021 | ▼ 22.0% |
| Current assets29/58 | €254,608 | €321,516 | €368,386 | €504,479 | €469,369 | ▼ 7.0% |
| Amounts receivable within one year40/41 | €50,515 | €66,367 | €49,864 | €68,694 | €4,251 | ▼ 93.8% |
| Trade receivables40 | - | - | €33,864 | €64,282 | €1,382 | ▼ 97.9% |
| Other amounts receivable41 | - | - | €16,000 | €4,412 | €2,870 | ▼ 35.0% |
| Current investments50/53 | €46,580 | €10,000 | €5,000 | €32,554 | €12,500 | ▼ 61.6% |
| Cash at bank and in hand54/58 | €157,514 | €244,958 | €313,332 | €399,373 | €380,352 | ▼ 4.8% |
| Deferred charges and accrued income490/1 | - | - | €190 | €3,859 | €72,266 | ▲ 1,773% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €430,884 | €509,292 | €508,567 | €589,592 | €535,529 | ▼ 9.2% |
| Equity10/15 | €175,993 | €488,431 | €142,783 | €234,326 | €519,279 | ▲ 122% |
| Contributions10/11 | €0 | - | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €157,393 | €469,831 | €124,183 | €215,726 | €500,679 | ▲ 132% |
| Non-distributable reserves130/1 | - | - | €1,860 | €0 | - | - |
| Reserves not available under the articles1311 | - | - | €1,860 | €0 | - | - |
| Distributable reserves133 | - | - | €122,323 | €215,726 | €500,679 | ▲ 132% |
| Profit (loss) carried forward14 | - | - | €0 | €0 | €0 | - |
| Amounts payable17/49 | €254,891 | €20,861 | €365,784 | €355,266 | €16,251 | ▼ 95.4% |
| Amounts payable within one year42/48 | €254,544 | €20,514 | €365,437 | €355,266 | €16,251 | ▼ 95.4% |
| Trade debts44 | €836 | €16 | €1,696 | €266 | €0 | ▼ 100% |
| Suppliers440/4 | - | - | €1,696 | €266 | €0 | ▼ 100% |
| Taxes, remuneration and social security45 | - | - | €654 | €0 | €11,250 | - |
| Taxes450/3 | - | - | €654 | €0 | €11,250 | - |
| Other amounts payable47/48 | - | - | €363,086 | €355,000 | €5,001 | ▼ 98.6% |
| Accrued charges and deferred income492/3 | - | - | €348 | €0 | - | - |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €217,436 | €332,438 | €314,352 | €446,543 | €359,953 | ▼ 19.4% |
| + Depreciation and write-downs630 | €43,562 | €48,240 | €48,566 | €55,069 | €18,952 | ▼ 65.6% |
| Operating cash flow (approximation) | €260,998 | €380,679 | €362,918 | €501,612 | €378,906 | ▼ 24.5% |
| Investment in fixed assets (approximation) | - | -€59,741 | -€971 | €0 | €0 | - |
| Change in cash | - | €87,444 | €68,374 | €86,041 | -€19,021 | ▼ 122% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Comparable companies
Similar companies · same sector, comparable size
OCULUS OOGARTSEN
BE 0787.990.584
Ieper · Eq €519,296
ENDODERM
BE 0655.942.209
Pont-à-Celles · Eq €518,959
DR JEROEN VAN HEVELE
BE 0741.882.526
Gavere · Eq €519,663
Dr. Ann Vandenbroucke
BE 0878.156.044
Jabbeke · Eq €518,728
DR. HEYSE ALEX, CARDIOLOOG
BE 0844.778.047
Kluisbergen · Eq €518,535
Of 16,625 companies in this sector we hold annual accounts for 7,989. 6,409 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Timeline
17 eventsLatest 28-10-2025
History
Acts, filings and financial milestones
2025
28-10
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 89 days late
2024
31-12
Financial
Liquidity times 20current ratio 28.88
Current ratio from 1.42 to 28.88; short-term debt falls from €355,266 to €16,251.
31-12
Financial
Equity above €500,000Eq €519,279 ▲122%
6 profitable years in a row build equity to €519,279.
01-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Highest result since 2019net €446,543 ▲42.1%
Operating result €591,952, net result €446,543, both a record.
31-12
Financial
Equity above €200,000Eq €234,326 ▲64.1%
5 profitable years in a row build equity to €234,326.
2022
07-12
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
21-01
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
30-06
Financial
Liquidity times 16current ratio 15.67
Current ratio from 1.00 to 15.67; short-term debt falls from €254,544 to €20,514.
30-06
Financial
Equity above €200,000Eq €488,431 ▲178%
3 profitable years in a row build equity to €488,431.
2020
22-12
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
30-06
Financial
Weakest financial yearnet €217,436 ▼6%
Net result drops to €217,436, the lowest in the series; recovery starts the following year.
Show earlier events
10-01
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
25-01
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
23-01
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
04-01
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
2015
18-12
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Support & recognitions
1 funding sourceFlanders €1,070
Flemish government
€1,070
awarded · 2024
Subsidies and aid
Flemish government
2024 · 1 entry · €1,070 awarded · €535 paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2024 | 1 | €1,070 | €535 |
Company details
Private limited company · founded 30-09-2013Year ends 31-12Peppol reachable1 site
Register details
Identification
Legal formPrivate limited company
Founded30-09-2013
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
85599Other education
Contact
E-mail
helenadevos@yahoo.comMerelbeke-Melle
Phone
0476/652504Merelbeke-Melle
E-invoicing
Reachable via Peppol
Peppol ID
0208:0539830338
Also
9925:BE0539830338
Registered
26-11-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 1 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Sites & property
Location & real-estate footprint
Registered office, Merelbeke-Melle · 1 establishment unit since 2013
Ground area
1,952 m²
Building footprint
349 m²
Volume, LiDAR
1,661 m³
Parcel 44412B0158/00V007, Flanders · tallest building 15.1 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
Dr. Helena Devos
since 2013unit no. 2.223.097.765
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44412B0158/00V007 | Flanders | 1,952 m² | 1 · 349 m² | 15.1 m · 1 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies How does this company compare with its sector?Sector benchmark
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.